399 related articles for article (PubMed ID: 30390679)
1. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
Henjum K; Almdahl IS; Årskog V; Minthon L; Hansson O; Fladby T; Nilsson LN
Alzheimers Res Ther; 2016 Apr; 8(1):17. PubMed ID: 27121148
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
[TBL] [Abstract][Full Text] [Related]
4. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Heslegrave A; Heywood W; Paterson R; Magdalinou N; Svensson J; Johansson P; Öhrfelt A; Blennow K; Hardy J; Schott J; Mills K; Zetterberg H
Mol Neurodegener; 2016 Jan; 11():3. PubMed ID: 26754172
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.
Idland AV; Wyller TB; Støen R; Eri LM; Frihagen F; Ræder J; Chaudhry FA; Hansson O; Zetterberg H; Blennow K; Bogdanovic N; Brækhus A; Watne LO
J Alzheimers Dis; 2017; 55(1):371-379. PubMed ID: 27662296
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification.
Knapskog AB; Henjum K; Idland AV; Eldholm RS; Persson K; Saltvedt I; Watne LO; Engedal K; Nilsson LNG
Sci Rep; 2020 Sep; 10(1):15886. PubMed ID: 32985583
[TBL] [Abstract][Full Text] [Related]
8. Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis.
Liu D; Cao B; Zhao Y; Huang H; McIntyre RS; Rosenblat JD; Zhou H
Neurosci Lett; 2018 Nov; 686():10-16. PubMed ID: 30171911
[TBL] [Abstract][Full Text] [Related]
9. The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.
Park SH; Lee EH; Kim HJ; Jo S; Lee S; Seo SW; Park HH; Koh SH; Lee JH
Sci Rep; 2021 Jun; 11(1):13050. PubMed ID: 34158530
[TBL] [Abstract][Full Text] [Related]
10. Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease.
Morenas-Rodríguez E; Alcolea D; Suárez-Calvet M; Muñoz-Llahuna L; Vilaplana E; Sala I; Subirana A; Querol-Vilaseca M; Carmona-Iragui M; Illán-Gala I; Ribosa-Nogué R; Blesa R; Haass C; Fortea J; Lleó A
Sci Rep; 2019 May; 9(1):7803. PubMed ID: 31127154
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
Li TR; Lyu DY; Liu FQ;
J Alzheimers Dis; 2022; 90(3):1123-1138. PubMed ID: 36213998
[TBL] [Abstract][Full Text] [Related]
12. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.
Wilson EN; Swarovski MS; Linortner P; Shahid M; Zuckerman AJ; Wang Q; Channappa D; Minhas PS; Mhatre SD; Plowey ED; Quinn JF; Zabetian CP; Tian L; Longo FM; Cholerton B; Montine TJ; Poston KL; Andreasson KI
Brain; 2020 Mar; 143(3):932-943. PubMed ID: 32065223
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease.
Wang ZB; Ma YH; Sun Y; Tan L; Wang HF; Yu JT;
J Neuroinflammation; 2022 Dec; 19(1):316. PubMed ID: 36578067
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
Halaas NB; Zetterberg H; Idland AV; Knapskog AB; Watne LO; Blennow K
J Alzheimers Dis; 2021; 81(2):667-677. PubMed ID: 33814433
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
[TBL] [Abstract][Full Text] [Related]
17. Association of insulin resistance with delirium and CSF biomarkers of Alzheimer's disease in elderly patients with hip fracture.
Wang J; Shuang P; Li Z; Zhao L; Wang X; Liu P
Aging Clin Exp Res; 2023 Jul; 35(7):1521-1529. PubMed ID: 37166562
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease.
Hok-A-Hin YS; Del Campo M; Boiten WA; Stoops E; Vanhooren M; Lemstra AW; van der Flier WM; Teunissen CE
J Neuroinflammation; 2023 May; 20(1):107. PubMed ID: 37147668
[TBL] [Abstract][Full Text] [Related]
19. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
20. Biological correlates of elevated soluble TREM2 in cerebrospinal fluid.
Winfree RL; Dumitrescu L; Blennow K; Zetterberg H; Gifford KA; Pechman KR; Jefferson AL; Hohman TJ;
Neurobiol Aging; 2022 Oct; 118():88-98. PubMed ID: 35908327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
